Theralase Technologies Inc. V.TLT

Certainly the impact of this will add value IMHO

[Oden6570]

Rutherrin® has been designed for intravenous administration and has demonstrated preclinically to be highly effective in a number of established animal models of human cancer, including Non-Muscle Invasive Bladder Cancer (“NMIBC”), Glio Blastoma Multiforme (“GBM”) and Non-Small Cell Lung Cancer (“NSCLC”).

To date, Theralase® has been issued 13 patents for cancer and therapeutic applications and has an additional 34 patents pending in various application stages in the United States, the European Union, Brazil, Russia, India and China.

These countries account for approximately 65% of the world’s Gross Domestic Product (“GDP”) (2015 statistics). If and when these patents are granted, it will allow Theralase® to fully commercialize and protect the Rutherrin® technology in these major healthcare markets.

Sounds Like a Job for Pandora ! Perhaps he would be kind enough to due some digging on stutus of patents.

Research Publications | Theralase Technologies Inc. – Theralase Technologies

[menoalittle]

While that is certainly true, I think it probably only scratches the surface of it's potential (and hopefully eventual) application and value in treating metastasis cancer (in the liver, and elsewhere) AND in the adjunct treatments of both pre and post surgical procedures to remove carcinomas (colon resections being perhaps the most common.)   ______________________ Rutherrin®&

[DeathXray33]

"Of all the microbes on the planet, viruses are the most abundant, with an estimated nonillion (10^30) in the ocean alone. And of course we know viruses can be airborne - that is one of their major transmission methods. Previously, the USDA Forest Service established that over a trillion viruses per square metre rains down every year. That, as it turns out, is a conservative figure. "

[Pandora]

 Yes Oden I have about 4 TLT - USPTO patents that I am currently tracking but they are mostly spinning their wheels i.e. TLT submits and USPTO rejects, and back and forth they go. I will post what ever if any progress is made.

[Pandora]

One of the Patents with a request for extension of time which is requested today: 17/008,497 | T1081/20077: APPARATUS AND METHOD FOR IRRADIATING INSIDE AN OBJECT Documents Transactions     Showing 5 of 76 entries     10/07/2024

[Tarbaby]

Good work.. I just wish TLT would demonstrate positively that Rutherrin is ssfe to inject into humans. This is still not stated by them. At least inject it into some live animals as a proxy to see what dose is tolerated. Almost all their cancer and virus treatments must hinge on that factor.

[2b7f6fab]

I thought the non-GMP performed in house was to determine the safety of infusion with live animals?  Just need more funds for third party validation of GMP demonstration.